Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
AVIGEN INC (AVGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/24/2009 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/22/2009 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
12/16/2009 8-K Quarterly results
12/15/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/09/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12/07/2009 8-K/A Financial Statements and Exhibits
Docs: "Amendment to Management Transition Plan, effective as of August 20, 2009"
11/09/2009 10-Q Quarterly Report for the period ended September 30, 2009
10/23/2009 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
09/24/2009 SC 13G/A Bulldog Investors reports a 3.8% stake in Avigen Inc.
08/26/2009 8-K Form 8-K - Current report
08/25/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/25/2009 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among MediciNova, Inc., Absolute Merger, Inc. and Avigen, Inc",
"Amendment to Rights Agreement, by and between Avigen, Inc. and American Stock Transfer & Trust Co. LLC",
"Amendment to Management Transition Plan, effective as of August 20, 2009",
"JOINT PRESS RELEASE OF AVIGEN AND MEDICINOVA, DATED AUGUST 21, 2009"
08/24/2009 425 Form 425 - Prospectuses and communications, business combinations
08/11/2009 8-K Quarterly results
Docs: "Avigen Reports Second Quarter 2009 Financial Results"
08/10/2009 10-Q Quarterly Report for the period ended June 30, 2009
06/25/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/25/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination SAN DIEGO and ALAMEDA, Calif., June 25, 2009 -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange , and Avigen, Inc. , a biopharmaceutical company, today announced that they have confirmed their understanding of certain key terms for a proposed acquisition of Avigen by MediciNova that would combine the companies' broad neurological clinical development programs based on ibudilast . MediciNova and Avigen currently contemplate that the terms of the merger would provide that Avigen shareholders receive consideration approximating Avigen's net cash liquidation value plus $3 million. Avigen shareholders woul..."
06/17/2009 SC 13G Bulldog Investors reports a 5.6% stake in Avigen Inc.
06/11/2009 SC 13G/A Odyssey Value Advisors, LLC reports a 0.4% stake in OMB Number 3235-0145 Avigen Inc
05/11/2009 10-Q Quarterly Report for the period ended March 31, 2009
05/11/2009 8-K Form 8-K -- Current report
04/29/2009 10-K/A Annual Report for the period ended December 31, 2008 [amend]
04/22/2009 8-K Form 8-K -- Current report
04/07/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
04/01/2009 8-K Form 8-K -- Current report
03/26/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/26/2009 8-K Form 8-K -- Current report
03/23/2009 DFAN14A Form DFAN14A -- Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
03/23/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/20/2009 DFAN14A Form DFAN14A -- Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
03/20/2009 SC TO-T/A Form SC TO-T/A -- Tender offer statement by Third Party [amend]
03/19/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/18/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/16/2009 10-K Annual Report for the period ended December 31, 2008
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy